The Impact of Remission and Low Disease Activity Attainment on Health-related Quality of Life in Two Phase III Clinical Trials of Belimumab in Systemic Lupus Erythematosus

被引：0
|
作者：
Emamikia, Sharzad [1 ]
Oon, Shereen [2 ]
Gomez, Alvaro [1 ]
Lindblom, Julius [1 ]
Borg, Alexander [1 ]
Enman, Yvonne [1 ]
Morand, Eric [3 ]
Grannas, David [4 ]
van Vollenhoven, Ronald [5 ]
Nikpour, Mandana [6 ]
Parodis, Ioannis [1 ,7 ]
机构：
[1] Karolinska Univ Hosp, Karolinska Inst, Div Rheumatol, Dept Med Solna, Stockholm, Sweden
[2] St Vincents Hosp, Dept Rheumatol, Fitzroy, Vic, Australia
[3] Monash Univ, Sch Clin Sci Monash Hlth, Monash Med Ctr Clayton, Fac Med Nursing & Hlth Sci, Melbourne, Australia
[4] Karolinska Inst, Inst Environm Med, Div Biostat, Stockholm, Sweden
[5] Univ Amsterdam, Dept Rheumatol & Clin Immunol, Amsterdam Rheumatol Ctr, Med Ctr, Amsterdam, Netherlands
[6] Univ Melbourne, St Vincents Hosp, Melbourne, Australia
[7] Orebro Univ, Fac Med & Hlth, Dept Rheumatol, Orebro, Sweden
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1261
引用
收藏
页码：2604 / 2606
页数：3
相关论文
共 50 条
  • [31] The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With SystemicLupus Erythematosus
    Parodis, Ioannis
    Benavides, Angie H. Lopez
    Zickert, Agneta
    Pettersson, Susanne
    Moller, Sonia
    Henriksson, Elisabet Welin
    Voss, Anne
    Gunnarsson, Iva
    ARTHRITIS CARE & RESEARCH, 2019, 71 (06) : 811 - 821
  • [32] Impact of disease activity on health-related quality of life in systemic lupus erythematosus-a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)
    Chaigne, Benjamin
    Chizzolini, Carlo
    Perneger, Thomas
    Trendelenburg, Marten
    Huynh-Do, Uyen
    Dayer, Eric
    Stoll, Thomas
    von Kempis, Johannes
    Ribi, Camillo
    BMC IMMUNOLOGY, 2017, 18
  • [33] Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
    Morand, E. F.
    Abreu, G.
    Furie, R. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (05)
  • [34] Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
    Morand, Eric F.
    Abreu, Gabriel
    Furie, Richard A.
    Golder, Vera
    Tummala, Raj
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (05) : 639 - 645
  • [35] Measures of Health-Related Quality of Life in Pediatric Systemic Lupus Erythematosus
    Hersh, Aimee
    ARTHRITIS CARE & RESEARCH, 2011, 63 : S446 - S453
  • [36] Health-Related Quality of Life Measurement in Adult Systemic Lupus Erythematosus
    Yazdany, Jinoos
    ARTHRITIS CARE & RESEARCH, 2011, 63 : S413 - S419
  • [37] Health-Related Quality of Life Measures in Adult Systemic Lupus Erythematosus
    Izadi, Zara
    ARTHRITIS CARE & RESEARCH, 2020, 72 : 577 - 592
  • [38] Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus.
    Lai, Jin-Shei
    Kaiser, Karen
    Beaumont, Jennifer
    Jensen, Sally
    Kao, Amy H.
    Van Brunt, David
    Chen, Shih-Yin
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1146 - S1147
  • [39] Health-related quality of life in patients with systemic lupus erythematosus: An update
    Thumboo, Julian
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2007, 36 (02) : 115 - 122
  • [40] METABOLIC SYNDROME AND HEALTH-RELATED QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Margiotta, D. P. E.
    Basta, F.
    Vadacca, M.
    Dolcini, G.
    Pignataro, F.
    Vernuccio, A.
    Mazzuca, C.
    Navarini, L.
    Afeltra, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 304 - 305
12345